Quick Answer
NUTRA PHARMA CORP reported Operating Income of -$878.4 thousand for fiscal year 2024.
NUTRA PHARMA CORP Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$878.4K | +1.0% |
| 2023 | -$887.0K | +53.5% |
| 2022 | -$1.91M | +4.1% |
| 2021 | -$1.99M | -115.0% |
| 2020 | -$924.9K | +24.8% |
| 2019 | -$1.23M | +34.5% |
| 2018 | -$1.88M | -36.0% |
| 2017 | -$1.38M | +32.4% |
| 2016 | -$2.04M | +64.6% |
| 2015 | -$5.77M | -161.8% |
| 2014 | -$2.20M | +6.7% |
| 2013 | -$2.36M | +9.2% |
| 2012 | -$2.60M | +34.2% |
| 2011 | -$3.95M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | -$290.5K | -32.4% | -57.3% |
| September 30, 2024 | -$184.8K | -11.5% | +15.8% |
| June 30, 2024 | -$219.5K | -20.4% | +25.7% |
| March 31, 2024 | -$295.3K | +25.9% | -78.1% |
| September 30, 2023 | -$165.8K | +29.9% | +9.1% |
| June 30, 2023 | -$182.3K | +46.6% | +54.3% |
| March 31, 2023 | -$398.7K | -29.3% | -68.6% |
| September 30, 2022 | -$236.5K | +53.8% | +30.7% |
- NUTRA PHARMA CORP showed an increase of +1.0% in Operating Income compared to the prior fiscal year.
- Over the 2011–2024 period, NUTRA PHARMA CORP’s operating income has grown by 77.8% (from -$3.95 million to -$878.4 thousand).
- The most recent figure is from NUTRA PHARMA CORP’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: